Regeneron to buy back $5 billion stake held by Sanofi
Regeneron Pharmaceuticals, Inc. to repurchase about $5 billion of its shares directly from France’s Sanofi, without altering their over-a-decade-long partnership.
Regeneron Pharmaceuticals, Inc. to repurchase about $5 billion of its shares directly from France’s Sanofi, without altering their over-a-decade-long partnership.